Related Experiment Video
Updated: Sep 14, 2026
Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection
Published on: July 21, 2022
Development and characterization of nonpeptidic small molecule inhibitors of the XIAP/caspase-3 interaction
Tom Y H Wu1, Klaus W Wagner, Badry Bursulaya
1The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Abstract:
Elevated expression of inhibitor of apoptosis protein (IAP) family members in various types of cancers is thought to provide a survival advantage to these cells. Thus, antiapoptotic functions of IAPs, and their potential as novel anticancer targets have attracted considerable interest. Among the IAPs, the X chromosome-linked inhibitor of apoptosis protein (XIAP) is regarded as the most potent suppressor of mammalian apoptosis through direct binding and inhibition of caspases. A high-throughput biochemical screen of a combinatorial chemical library led to the discovery of a novel nonpeptidic small molecule that has the ability to disrupt the XIAP/caspase-3 interaction. The activity of this nonpeptidic small molecule inhibitor of the XIAP/caspase-3 interaction has been characterized both in vitro and in cells. Molecules of this type can be used to conditionally inhibit the cellular function of XIAP and may provide insights into the development of therapeutic agents that act by modulating apoptotic pathways.
Insights
Researchers discovered a novel small molecule that disrupts the interaction between inhibitor of apoptosis proteins (IAPs) and caspases. This finding offers a new strategy for developing cancer therapeutics by targeting apoptosis pathways.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Inhibitor of Apoptosis Proteins (IAPs) are upregulated in cancers, promoting cancer cell survival.
- X-linked inhibitor of apoptosis protein (XIAP) is a potent suppressor of apoptosis by inhibiting caspases.
- Targeting IAPs presents a promising strategy for novel anticancer drug development.
Purpose of the Study:
- To discover and characterize novel small molecules that inhibit the XIAP/caspase-3 interaction.
- To explore the potential of these molecules as therapeutic agents for cancer treatment.
Main Methods:
- High-throughput biochemical screening of a combinatorial chemical library.
- In vitro and cellular assays to characterize the activity of identified small molecules.
- Investigating the disruption of XIAP/caspase-3 interaction.
Main Results:
- Discovery of a novel nonpeptidic small molecule inhibitor.
- Demonstrated ability of the molecule to disrupt the XIAP/caspase-3 interaction.
- Characterization of the inhibitor's activity in both biochemical and cellular contexts.
Conclusions:
- Novel small molecules can effectively disrupt the XIAP/caspase-3 interaction.
- These molecules offer a potential mechanism for conditionally inhibiting XIAP function.
- This research provides insights for developing new therapeutic agents that modulate apoptotic pathways in cancer.
